INVESTORS & MEDIA

Latest News

Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular Edema

View Press Release View All

Rezolute Reports First Quarter Fiscal 2023 Results and Highlights Company Progress

Rezolute to Present at the Jefferies London Healthcare Conference

Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.